Treatment and survival of patients with chronic myeloid leukaemia in Europe

New intelligence network that supports efforts to improve quality of care and development of new medicines

Non-randomised clinical trial aims to describe the safety and efficacy of commercially available, targeted anticancer drugs

Developments in clinical trials and health information technology that will improve targeted therapies for patients

New targeted treatments for blood cancers: Multiple myeloma, non-Hodgkin lymphoma, genomic marker mismatch repair and myelofibrosis

New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia

ecancermedicalscience editor's choice for May 2015

How will genomics be applied to patient therapy in future?

Assessing comborbid pain and opioid addiction

The main barriers to palliative care and how we should overcome them

How palliative care in India has changed and the importance of e-learning

Establishing palliative care in Tanzania, Africa